Overview

Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

Status:
NOT_YET_RECRUITING

Trial end date:
2029-12-30

Target enrollment:

Participant gender:

Summary

Evaluation of the efficacy and safety of Thiotepa combined with Cyclophosphamide and Busulfan as conditioning regimen before allo-HSCT for the treatment of NK/T cell lymphoma

Phase:

PHASE2

Details

Lead Sponsor:

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Treatments:

Thiotepa